Division of Allergy, Pulmonary and Critical Care Medicine in the Department of Medicine, Vanderbilt University, T1218 MCN, 1161 21st Avenue South, Nashville, TN, USA.
Ann Intensive Care. 2014 Feb 24;4(1):5. doi: 10.1186/2110-5820-4-5.
The aim of this study was to determine the association between 25-hydroxyvitamin D (25-OHD) levels at the onset of critical illness and the development of acute lung injury/acute respiratory distress syndrome (ALI/ARDS) in patients with sepsis or trauma.
We performed two nested case-control studies of 478 patients with sepsis and trauma with or without ALI/ARDS admitted to the medical, surgical and trauma ICUs of a tertiary-care center. Cases consisted of patients with either sepsis or trauma and ALI/ARDS; controls consisted of equivalent numbers of matched patients with either sepsis or trauma alone. We measured serum 25-OHD levels the morning after ICU admission and used multivariable regression to assess the relationship between 25-OHD and diagnosis of ALI/ARDS during the first four ICU days, controlling for age, gender, diabetes, smoking status and season.
25-OHD levels did not differ between cases with ALI/ARDS and controls in either the sepsis or trauma cohorts. Using a conditional logistic regression model, sepsis patients during the winter season with higher 25-OHD levels were more likely to develop acute lung injury (odds ratio 1.68, 95% confidence interval of 1.05 to 2.69, P = 0.03). This association did not hold for the trauma cohort in either season. Sepsis and trauma patients had a lower risk of hospital mortality at higher 25-OHD levels but neither relationship reached significance. Higher one-year mortality after trauma was associated with lower 25-OHD levels (HR 0.50, CI 0.35,0.72 P = 0.001).
Serum 25-OHD measured early after admission to intensive care is not associated with the development of acute lung injury, hospital or one-year mortality in critically ill patients with sepsis although lower 25-OHD levels were associated with higher one-year mortality in patients with severe trauma.
本研究旨在确定危重病发病时 25-羟维生素 D(25-OHD)水平与脓毒症或创伤患者发生急性肺损伤/急性呼吸窘迫综合征(ALI/ARDS)的关系。
我们对入住一家三级护理中心的内科、外科和创伤重症监护病房的 478 例脓毒症或创伤患者进行了两项嵌套病例对照研究,这些患者中存在或不存在 ALI/ARDS。病例组由脓毒症或创伤合并 ALI/ARDS 的患者组成;对照组由数量相同的单纯脓毒症或创伤患者组成。我们在入住重症监护病房的次日清晨测量血清 25-OHD 水平,并采用多变量回归来评估在重症监护的前 4 天内 25-OHD 与 ALI/ARDS 诊断之间的关系,同时控制年龄、性别、糖尿病、吸烟状况和季节。
在脓毒症或创伤队列中,发生 ALI/ARDS 的病例组与对照组的 25-OHD 水平无差异。使用条件逻辑回归模型,冬季季节中 25-OHD 水平较高的脓毒症患者更有可能发生急性肺损伤(比值比 1.68,95%置信区间为 1.05 至 2.69,P=0.03)。但这种关联在任何季节的创伤队列中均不成立。脓毒症和创伤患者在 25-OHD 水平较高时住院死亡率较低,但这两种关系均无统计学意义。创伤后 1 年死亡率较高与 25-OHD 水平较低有关(HR 0.50,CI 0.35,0.72,P=0.001)。
入住重症监护病房早期测量的血清 25-OHD 水平与脓毒症危重病患者急性肺损伤、住院或 1 年死亡率均无相关性,但严重创伤患者的 25-OHD 水平较低与较高的 1 年死亡率相关。